Loading...
•
Mar 31, 2020
Bio-key Q4 2019 Earnings Report
BIO-key's Q1 2020 financial performance improved substantially compared to the same period in 2019, driven by gross profit improvement and decreased operating expenses.
Key Takeaways
BIO-key reported a decrease in Q1 2020 revenue, but a significant improvement in gross margin and a reduction in operating loss compared to Q1 2019. The company's focus on large African contracts positions it for substantial revenue growth in 2020.
Q1 2020 revenues declined to $530,000 from $552,000 in Q1 2019.
Gross margin improved to 67% in Q1 2020 versus a negative gross margin in Q1 2019.
Q1 2020 operating expenses declined to $1.7 million from $1.8 million.
Operating loss was reduced to $1.3M in Q1 2020 versus $1.8M in Q1 2019.
Revenue by Segment
Forward Guidance
BIO-key has a strong outlook for 2020 and expects to commence work on its large African contracts in the coming months, leading to substantial revenue growth.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...